This ensures food security for one year
In Ghana, we are helping smallholder farmers overcome hardship caused by the pandemic. Click here to read about this story and find out more.
Search
More Green
Our MORE GREEN pillar encompasses environmental initiatives that consider many different aspects. Click here to learn more about our MORE GREEN pillar.
BI India joins forces with PPAM and BMC to Stop Rabies
This initiative will adopt a two-pronged approach of vaccination and education.
Back to life
Anna Higgs had a severe stroke at the age of 24. For years she has been struggling with the consequences. Click here to learn more about her story.
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. Learn more.
Keep water clean
Human beings can’t survive without water. Further, the safe production of medicines depends on clean drinking water. Click here to find out more.
preventive care cat veterinarian
What can we all, as cat owners or veterinarians, do to promote cat health? Click here to read about this subject and find out more information.
COVID-19 Boehringer Ingelheim NL donates 440 oxygen meters
Boehringer Ingelheim donates 440 oxygen meters to lung specialists and general practitioners during the pandemic. Click here to find out more.
COVID-19 Joining forces against COVID-19
While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
More health in vulnerable communities
Making More Health, offers expertise, network and financial support to social entrepreneurs, plus more. Read more about Making More Health here.
10 years of Making More Health
10 years ago, Boehringer Ingelheim started the social initiative Making More Health together with our partner Ashoka. Watch the video here to learn more.
The Supplier Code of Conduct Download
Click here to download our supplier code of conduct. The Boehringer Ingelheim supplier code of conduct entered into force in 2016, and was updated in 2020.
COVID-19 Protecting Our Employees
We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
Transboundary and emerging diseases
We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks.
fighting pet parasites with holistic approach france
When animals are healthy, humans are healthier, too. This is especially true for parasitic diseases that affect our pets to whom we are close. Read more.
weBuy
weBuy is a key initiative in order to have an integrated solution for the Source to Procure Process around the globe. Click here to find out more.
Patient voices Ulrichs story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Ulrich's story.
Patient voices Eves story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Eve's story.
Patient voices Augustos story
Hear from patients and families on how atrial fibrillation (AF), deep vein thrombosis (DVT) and pulmonary embolism (PE) have affected their lives.
More Potential Overview
More Potential works to provide the best conditions for our people, communities and partners along our value chain. Click here to find out more.
COVID-19 Pandemic support in Vietnam
Find out how Boehringer Ingelheim Vietnam is joining hands with the government and hospitals. Click here to find out and learn more information.
COVID-Relief-India-2021
Boehringer Ingelheim prioritises life continuity to the underserved, in addition to medical aid. Click here to find out and learn more information.
COVID-19 IMI2–Call 21
CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
3 scopes for sustainability Saint Vulbas France
Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.
EMPRISE
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care. Click here to find out more information.